| Name | Title | Contact Details |
|---|
G Hartzell & Son is a Concord, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Access MediQuip, L.L.C. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Cochlear Limited is the leading global expert in implantable hearing solutions. For more than 30 years Cochlear has helped over 400,000 people connect to the world of sound. With a global team of over 2,800 passionate experts, Cochlear is an organisation you can be proud to work for. Our people say making a difference in the lives of others is the number one reason they enjoy working at Cochlear. With a range of solutions for different types of hearing loss, Cochlear maintains the industry’s largest investment in R&D. To improve our products and services we currently work in collaboration with over 100 research partners based in 20 countries. Cochlear’s mission of “Hear now. And always” embodies our commitment to providing life-time support. To build a sustainable global business, we are continually strengthening our internal capability and infrastructure, through the development of our people, processes and systems. As we continue to launch new products and services, our employees experience growth, change and opportunity right across the business. Joining the Cochlear team would see you collaborating with dedicated colleagues who share Cochlear’s core values of customer satisfaction, mutual respect, continuous improvement and innovation, performance and professionalism. Whatever career you chose at Cochlear, you will find the work interesting, challenging and rewarding.
Grand X-Ray Instrumentarium Imaging is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.